Skip to main content
Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review
Published Web Location
http://europepmc.org/articles/PMC3699597?pdf=renderNo data is associated with this publication.
Abstract
Background: Rituximab is an anti-CD20 monoclonal antibody approved for non Hodgkin lymphoma and rheumatoid arthritis. It is being considered for the treatment of MS. Objectives: To evaluate the efficacy and safety of rituximab for MS treatment. Data collec
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.